Phase I and dose-finding study of TS-1 with Abraxane for metastatic breast cancer
Phase 1
- Conditions
- metastatic breast cancer
- Registration Number
- JPRN-UMIN000006383
- Lead Sponsor
- Tokusima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1)male breast cancer 2)taboo to use TS-1 or Abraxane 3)had undergone treatment with TS-1 or Abraxane chemotherapy prior to this study 4)pregnant or nursing women or who like be pregnant.possible to pregnancy 5)with active double cancer 6)wiht severe complications 7)uncontrolled dropsy pleural effusion,abdominal dropsy 8)wiht brain metastasis 9)had a previos serious medical illness or allergy 10)doctor's decision not to be registered to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method